Esteve joins innovative HIV/AIDS partnership
This article was originally published in Scrip
Executive Summary
The Spanish chemical and pharmaceutical group Esteve is to collaborate with the IrsiCaixa AIDS Research Institute on the HIVACAT AIDS research project to develop an HIV vaccine.